Skip to main content
Figure 3 | Molecular Pain

Figure 3

From: Intraperitoneal administration of AAV9-shRNA inhibits target gene expression in the dorsal root ganglia of neonatal mice

Figure 3

Silencing effect of ssAAV9-sh SOD1 vector on mRNA expression level of SOD1. The qRT-PCR of SOD1 mRNA in DRG at 4 weeks (A) and 12 weeks (B) after injection with ssAAV9-shRNA vector shows that superoxide dismutase-1 (SOD1) expression was significantly inhibited (*P < 0.05). There is no significant difference of the expression level of SOD1 mRNA between ssAAV9-shSOD1 and control in the spinal cord (C).

Back to article page

Molecular Pain

ISSN: 1744-8069

Contact us